---
figid: PMC2613546__nihms79323f5
figlink: /pmc/articles/PMC2613546/figure/F5/
number: F5
caption: Diagram showing the interactions of the cell signaling studied in sensitive
  and resistant lines. Signaling in PX-866 sensitive tumors comes from an increased
  reliance on the PI-3-kinase pathway, arising from aberrant activation through growth
  factors (GF) or mutated components of the pathway itself (*). Tumors with an activated
  Ras protein show a minimal response to inhibition of the PI-3-kinase pathway due
  to a shared reliance on alternate signaling pathways including the Raf and RalGDS
  pathways.
pmcid: PMC2613546
papertitle: Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor
  activity of the inhibitor PX-866 while oncogenic Ras is a dominant predictor for
  resistance.
reftext: NathanT. Ihle, et al. Cancer Res. ;69(1):143-150.
pmc_ranked_result_index: '2396'
pathway_score: 0.9092405
filename: nihms79323f5.jpg
figtitle: Antitumor activity and resistance of the inhibitor PX-866
year: ''
organisms:
- Homo sapiens
ndex: 68de1b58-de8e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2613546__nihms79323f5.html
  '@type': Dataset
  description: Diagram showing the interactions of the cell signaling studied in sensitive
    and resistant lines. Signaling in PX-866 sensitive tumors comes from an increased
    reliance on the PI-3-kinase pathway, arising from aberrant activation through
    growth factors (GF) or mutated components of the pathway itself (*). Tumors with
    an activated Ras protein show a minimal response to inhibition of the PI-3-kinase
    pathway due to a shared reliance on alternate signaling pathways including the
    Raf and RalGDS pathways.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PIK3R5
  - PIK3CD
  - KRAS
  - PIK3CA
  - PIK3CB
  - PTEN
  - PIK3CG
  - PIK3R3
  - AKT2
  - NRAS
  - ARAF
  - AKT3
  - AKT1
  - BRAF
  - HRAS
  - RALGDS
  - RAF1
  - PIK3R4
  - PIK3R6
genes:
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: Akt*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Akt*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt*
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RalGDS
  symbol: RALGDS
  source: hgnc_symbol
  hgnc_symbol: RALGDS
  entrez: '5900'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI-3-K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals: []
diseases: []
figid_alias: PMC2613546__F5
redirect_from: /figures/PMC2613546__F5
figtype: Figure
---
